Loading

Slzii.com Search

Search (News)

The Muscle Remedy Healthcare Group Expands Beyond Founder-Led Clinic with First Satellite Location and Broader Healthcare Ecosystem
Founder and Clinic Managing Director Mr Salman Fitri marks a new phase of growth for the Singapore healthcare business, expanding into new locations, corporate wellness, consumer health products and strategic partnerships. SINGAPORE , Sept. 21, 2026 /PRNewswire/ -- The Muscle Remedy Pte Ltd has entered a new phase of expansion with the launch of its first satellite clinic in Bukit Timah , as the Singapore-based healthcare business develops from a founder-led practice into a broader, team-based healthcare group. Mr Salman Fitri (founder) of The Muscle Remedy Pte Ltd Located within a sports and performance gym in the heart of Bukit Timah, the new satellite clinic represents The Muscle Remedy's move towards a partnership-led expansion strategy, working with suitable fitness, rehabilitation and performance partners to extend its services into complementary environments. The milestone is the latest chapter in the entrepreneurial journey of Mr Salman Fitri, Founder and Clinic Managing Director of The Muscle Remedy Pte Ltd , who oversees the company's clinical direction, business strategy, team development, partnerships and expansion. Since establishing his own centre in 2019 and subsequently incorporating The Muscle Remedy Pte Ltd in 2021, Mr Salman has focused on developing the business beyond a practice dependent on a single practitioner. The company says it has now served more than 10,000 patients since its establishment. From Personal Pain to an Entrepreneurial Purpose The origins of The Muscle Remedy can be traced to Mr Salman's own experience with persistent back pain and his subsequent search for different approaches to care. Around 2014–2015 , he began developing practical experience across traditional, sports and manual therapy approaches. In 2019, he took the next step by establishing his own centre shortly before the COVID-19 pandemic. Navigating the business through the pandemic became an important test of its resilience and helped shape Mr Salman's approach to entrepreneurship. The Muscle Remedy Pte Ltd was subsequently incorporated in 2021 , setting the foundation for a more structured company and its longer-term expansion. Today, Mr Salman is working towards transforming the business from a clinic closely associated with its founder into an organisation supported by trained practitioners, internal standards, individual areas of specialisation and strategic partnerships. "The long-term goal is to build something sustainable that can grow beyond one practitioner," said Mr Salman. "The Muscle Remedy should be able to develop its people, build strong partnerships and create different pathways through which we can support our clients and communities." Growing The Muscle Remedy Beyond the Treatment Room The company's growth strategy now extends across clinical services, rehabilitation, movement, workplace wellness and other health-related initiatives. Its services and programmes include Fusion Therapy, osteopathy and manual therapy, Functional Gait Remedy, rehabilitation and recovery services, and corporate health and wellness programmes . At the centre of its clinical philosophy remains an assessment-first and consultation-led approach . Rather than automatically providing a technique requested by a patient including treatments they may have encountered through social media, the team first conducts a consultation to determine what may be appropriate within its scope. This consultation-first philosophy has been part of Mr Salman's approach since the clinic's early development. The company describes its signature Fusion Therapy concept as an approach that draws on relevant principles and modalities according to the individual needs identified through consultation and assessment. Where a person's needs fall outside The Muscle Remedy's scope, the company's wider healthcare ecosystem philosophy includes collaboration with and referral to other healthcare professionals. Bukit Timah Satellite Clinic Signals New Expansion Strategy The launch of The Muscle Remedy's first satellite clinic in Bukit Timah marks a significant step in that growth strategy. Rather than limiting future expansion to standalone clinics, The Muscle Remedy intends to explore opportunities with suitable fitness, rehabilitation and performance partners , allowing its services to operate within environments that complement movement, recovery and physical performance. The Bukit Timah location, situated within a sports and performance gym, serves as the first example of this model. For the company, the strategy represents an opportunity to expand its physical presence while building relationships with organisations operating in complementary areas of health and performance. Healthy Work Hub Extends the Business into Corporate Wellness The Muscle Remedy is also broadening its reach beyond individual care through Healthy Work Hub , its corporate wellness sector. Healthy Work Hub works in partnership with a sports physiotherapy clinic to support corporate wellness events, employee programmes and educational workshops . Its programmes focus on areas including workplace wellbeing, physical strain, movement, posture, recovery, injury prevention and employee performance. The initiative forms part of The Muscle Remedy's strategy to address health and wellbeing across different settings from individual consultations and rehabilitation to workplace education and employee wellness. Expanding into Nursing Support and Consumer Health Mr Salman's entrepreneurial activities also extend beyond The Muscle Remedy. He serves as a Director of AnistarCare Pte Ltd , a Singapore nursing care agency providing nursing and related healthcare support. His involvement in the company reflects his broader interest in creating connections across different areas of healthcare beyond outpatient clinical care. In 2025 , Mr Salman also launched TurmoRelief , short for "Turmeric Modern Relief" , his first natural nine-in-one health supplement. TurmoRelief represents The Muscle Remedy's first move into the consumer health product segment and another step in diversifying the business beyond clinic-based services. Business Growth Recognised Through Singapore SME Awards The Muscle Remedy's entrepreneurial journey has also received several business and enterprise recognitions. These include the Golden Bull Award 2023 – Emerging SME , SME500 Singapore Award 2023 , Top Service & Quality & Business Excellence Award 2023 , and Spirit of Enterprise Neo Start Up Award recognition in 2024 . Mr Salman was also featured in Successful Entrepreneurs in Singapore & Malaysia Book Vol 8 by British Publishing House. The recognitions reflect a period in which The Muscle Remedy has been evolving from a single founder-led clinic towards a company encompassing multiple services, programmes, partnerships, products and locations. Building a Business That Can Grow Beyond Its Founder The next phase of The Muscle Remedy's development will place greater emphasis on its people. Mr Salman is working towards a team structure built around internal standards, practitioner training and individual areas of specialisation , with the objective of creating a company that is not entirely dependent on one practitioner. The longer-term ambition is to create an integrated healthcare ecosystem spanning individual care, rehabilitation, movement, workplace wellness, consumer health products and nursing support , alongside collaboration with other healthcare professionals when needs fall outside the company's scope. For Mr Salman, the expansion represents a shift from building a practice around his own capabilities to building an organisation capable of growing through its people, partnerships and systems. "What started from my own experience with pain has grown into something much bigger," said Mr Salman. "The next chapter is about building a sustainable healthcare business, developing our team and creating an ecosystem that can continue growing beyond me." About The Muscle Remedy Pte Ltd The Muscle Remedy Pte Ltd is a Singapore-based healthcare, osteopathy and manual therapy business founded by Mr Salman Fitri , who serves as Founder and Clinic Managing Director. Its services and programmes include Fusion Therapy, osteopathy and manual therapy, Functional Gait Remedy, rehabilitation and recovery services, and corporate health and wellness programmes. The company is developing from a founder-led clinic into a team-based healthcare group supported by multiple services, programmes, products, partnerships and locations, with a longer-term vision of contributing to a more connected healthcare ecosystem. Website: https://themuscleremedy.com/
2026-09-21 07:14:00

BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
SHANGHAI , Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for Biopharma, Health for All," this year's event brings together innovation resources from around the world to foster an open, collaborative innovation ecosystem for the biopharmaceutical industry. The opening ceremony marked the launch of the "Connect Globally: Shanghai–London Life Sciences Innovation Partnership." The ceremony was attended by representatives of Chinese and British institutions, including Zhangjiang Group, Shanghai Minhang Biomedical Industry Development Co., Ltd., Shanghai Jiading Industrial Zone Development (Group) Co., Ltd., London & Partners, Imperial College London, and Oxford University Innovation. Going forward, London Life Sciences Week and BioShanghai Week will work more closely to connect research capabilities, industry resources, and innovation platforms in life sciences across China and the UK, creating an open, efficient platform for international exchange and cooperation. The ceremony also unveiled the "Empower the Future: BioShanghai Investment and Financing Ecosystem Partnership," bringing together representatives from domestic and foreign equity investment and financial institutions. These included Shanghai Industrial Investment (Holdings) Co., Ltd., Shanghai State-owned Capital Investment Co., Ltd., Advantech Capital, CBC Group, Pudong Venture Capital Group, GL Ventures, HongShan, Jefferies Financial Group, Guotai Haitong Securities, New Alliance Capital, YUNION Healthcare Ventures, and Shanghai Hongsheng Capital. Together, these partners will work to align capital with industry and build a biopharmaceutical capital ecosystem that supports companies at every stage of their life cycle. The BioShanghai Week 2026 officially opened. Running from September 17 to 20, this event follows a "1+5+1+1" framework: one opening ceremony, five thematic tracks, one exhibition with matchmaking sessions, and one Bio-Tour of industry sites. It brings together entrepreneurs, investors, scientists, clinical PIs, and other key players to address practical challenges in frontier technologies, research commercialization, industry collaboration, and business growth. Activities are organized around five themes: Innovation Integration, Clinical Translation, Capital Empowerment, Ecosystem Services, and Coordinated Healthcare Development. To connect resources efficiently, formats such as "One Room One Topic," closed-door discussion, project roadshows, one-on-one meetings, and Bio-Tour are adopted. This year, BioShanghai Week returns with an upgraded format, aiming to position itself as a global bellwether for cutting-edge biopharmaceutical technologies and a gateway for cross-border collaboration. Over the years, Zhangjiang Pharma Valley has become an internationally recognized and influential signature brand of the biopharmaceutical industry. Pairing BioShanghai Week with the Zhangjiang brand will further raise both the profile and market vitality of Zhangjiang Pharma Valley, creating a premier annual dealmaking summit that connects global capital with Chinese pharmaceutical innovation and takes Chinese breakthroughs to global markets. These efforts will support Shanghai's ambition to become "the world's most supportive city for innovative drugs and medical devices." The 2026 Jiading District Biopharmaceutical Industry Development Promotion Conference and the 2026 Minhang District Biopharmaceutical Ecosystem Promotion Conference were held on the same day. Both events support Shanghai's drive to develop high-end medical device industry clusters and help land innovation resources and outcomes in the city.
2026-09-20 05:11:00

SMU MBA rises to 3rd in Asia in 2027 QS Global MBA Rankings
Highest Asian ranking to-date underscores growing employer recognition and academic strength SMU Master of Science in Applied Finance also ranks 3rd in Asia SINGAPORE , Sept. 18, 2026 /PRNewswire/ -- Singapore Management University's (SMU) Master of Business Administration (MBA) has reached a new high in the 2027 QS Global MBA Rankings, rising to 3rd in Asia, its highest regional position to date, and ranking 41st globally. SMU Lee Kong Chian School of Business The result marks the third consecutive year that the SMU MBA has risen in Asia, climbing from 6th in 2024 to 5th in 2025, 4th in 2026 and now 3rd in 2027. It is the second highest ranked MBA programme in Singapore and remains within the top 10 per cent of more than 400 MBA programmes assessed worldwide. The strong showing is underpinned by gains in employer recognition and graduate employment, alongside a 4th-place ranking in Asia for Thought Leadership, highlighting the combination of strong career outcomes and academic excellence that defines the SMU MBA experience. SMU Master of Science in Applied Finance also ranks 3rd in Asia SMU's strong performance also extends to the 2027 QS Master's in Finance Rankings, where its Master of Science in Applied Finance (MAF) ranks 3rd in Asia and 39th globally. It remains the only finance master's programme in Singapore included in the rankings, as the field expanded significantly from 248 programmes last year to 319 this year. Academic strength with impact Thought Leadership was another area of strength, with both programmes ranking among the world's Top 40, with the MBA at 33rd and the MAF at 19th. These results underscore SMU's Lee Kong Chian School of Business (LKCSB)'s growing standing as a source of influential research and ideas that contribute to business and management thinking. Almost all teaching faculty at SMU's LKCSB hold doctorates, bringing deep academic expertise and research insights into the classroom. The growing influence of their research is also reflected in this year's rankings, with research impact improving for both the MBA and MAF. Students across the MBA and MAF learn from well-qualified faculty in their areas of expertise, giving them access to current thinking and research that can be applied to real-world business challenges. Professor Shantanu Bhattacharya, Deputy Dean (Education) at SMU's Lee Kong Chian School of Business, said: "Our MBA and MAF both ranking 3rd in Asia is a strong affirmation of the quality of an SMU business education and the progress we have made over several years. This recognition reflects the calibre of our faculty, the relevance and impact of their research, and the value employers place on our graduates. We are particularly encouraged by the growing recognition from employers, which speaks to the capabilities and perspectives our graduates bring to the workplace. In the latest graduate employment survey, 86% and 78% of our MBA and MAF postgraduate students secured employment within six months of graduation respectively. Our focus remains on delivering an education that equips our students to advance their careers, seize new opportunities and lead with confidence in a dynamic and rapidly evolving Asia." Both the MBA and the MAF are offered by the University's Lee Kong Chian School of Business (LKCSB). The 2027 QS Global MBA and Master's in Finance rankings assessed more than 400 MBA programmes and 319 Master's in Finance programmes globally, respectively. Both rankings draw on extensive feedback from employers and academics worldwide and assess programmes across five areas: Employability, Alumni Outcomes, Thought Leadership, Value for Money and Diversity. About Singapore Management University (SMU) Established in 2000, Singapore Management University (SMU) is recognised for its high-impact, multi-disciplinary research that addresses Asian issues of global relevance, and for its interactive, collaborative and project-based approach to learning. Home to over 13,000 students across six schools and two colleges, SMU offers bachelors, masters and PhD programmes across Accountancy, Business, Economics, Information Systems, Integrative Studies, Law and Social Sciences, as well as executive development and continuing education programmes. SMU graduates are consistently ranked among the most employable in Singapore, and command one of the highest mean starting salaries. Through its city campus, SMU enjoys strategic linkages with business, government and the wider community in Singapore and beyond. www.smu.edu.sg
2026-09-18 01:00:00

Meet 'Shin Duty Free Sale': Shinsegae's New Mega Sale Event
Four times a year, the new signature event brings affordable luxury, beauty, fashion and spirits to travelers at special duty-free prices. SEOUL, South Korea , Sept. 18, 2026 /PRNewswire/ -- Shinsegae Duty Free is launching 'Shin Duty Free Sale,' a new signature shopping event designed to give travelers four opportunities each year to discover exceptional duty-free deals on luxury, beauty, fashion, spirits and more. Held around Korea's major holidays and extended travel periods, Shin Duty Free Sale brings together customer-favorite brands, best-selling products and exclusive offerings available only at Shinsegae Duty Free. The event will become a recurring quarterly promotion, giving both domestic and international travelers a new reason to shop with Shinsegae throughout the year. The inaugural Shin Duty Free Sale runs September 17 through October 11 , both online and at Shinsegae Duty Free's Myeongdong store, timed to Korea's extended Chuseok holiday period and the consecutive public holidays of National Foundation Day and Hangeul Day. The name 'Shin Duty Free Sale' uses 'Shin,' a friendly shortened reference to Shinsegae Duty Free, to create a more approachable and memorable name for the company's flagship promotional event. Affordable Luxury Takes Center Stage The inaugural event centers on "Affordable Luxury," offering a curated selection of luxury brands and best sellers at attractive duty-free prices. The promotion spans fashion and accessories, leather goods, cosmetics and fragrance, spirits and other popular categories. Online, a total of 3,800 products from 277 brands will be available at discounts of up to 70%. Among these, approximately 2,200 highly sought-after cosmetics and fragrance products from 173 customer-favorite brands will be offered at discounts of up to 60% off. Participating brands include major international beauty brands include names such as YSL Beauty, Lancôme, Kiehl's, Prada Beauty (Fragrance), and Swiss Just, alongside THOME, a highly popular beauty device brand. Yunjac: up to 40% off VIDIVICI: up to 49% off Swiss Perfection: up to 30% off AMUSE: up to 48% off DEWARSOME: up to 49% off In addition, Shinsegae Duty Free's exclusive brands will also offer major savings: The A Effect: up to 50% off Sunshuruup: up to 50% off Beyond cosmetics and fragrances, the online sale showcases approximately 1,300 highly preferred products from 83 brands across fashion, accessories, and leather goods. To further elevate the shopping experience, a selection of 160-plus exclusive products and specialized promotional items from Shinsegae Duty Free's sole brands will be featured, adding a distinct and differentiated value. At Shinsegae Duty Free's Myeongdong flagship, shoppers can explore approximately 290 products from 85 premium brands—including Sulwhasoo, The History of Whoo, Anua, and Biotherm—all at discounts of up to 40%. To keep the selection fresh throughout the 25-day event, Shinsegae Duty Free is tailoring product assortments to each sales channel based on customer preferences and will rotate featured products and benefits during the promotion. Special Experiences for Travelers The inaugural Shin Duty Free Sale will also feature a series of themed promotions that go beyond traditional price discounts. Through "Captain Ttager PICK," a spirits-focused campaign created in collaboration with Captain Ttager, one of South Korea's leading travel content creators with more than 770,000 YouTube subscribers, shoppers can discover special offers on popular spirits including Glenfiddich and The Balvenie. The "Amore Beauty Shinsegae" Brand Week , presented in partnership with Amorepacific, will showcase best-selling products from leading brands including Sulwhasoo, HERA and AESTURA , along with Shinsegae Duty Free-exclusive sets and special purchase benefits. Two Waves of Offers During Korea's Golden Holiday Season The inaugural Shin Duty Free Sale will be divided into two promotional waves to coincide with travelers' holiday schedules. Wave 1: September 17–30 Wave 2: October 1–11 Featured products and benefits will change between the two waves, giving travelers additional opportunities to discover different products and offers depending on when they travel. "Shin Duty Free Sale brings together the products our customers love—from luxury and beauty to fashion and spirits—along with exclusive experiences and offers that can only be found at Shinsegae Duty Free," said a Shinsegae Duty Free representative. "We plan to make Shin Duty Free Sale a signature shopping event, returning four times a year around Korea's major holidays and peak travel periods." The first Shin Duty Free Sale runs September 17 through October 11, 2026 , online and at Shinsegae Duty Free Myeongdong.
2026-09-18 00:17:00

Devexperts Brings US Equity Markets Access to Brokers in South Korea
SEOUL, South Korea , Sept. 17, 2026 /PRNewswire/ -- Devexperts , the global software developer for the capital markets, has announced that it is now delivering access to US equity markets for brokers in South Korea, via a single, turnkey solution complete with a front-end trading platform, integrated market data feeds, and full execution services. The solution is powered by Devexperts' flagship, off-the-shelf trading platform, DXtrade . It features an end-to-end US equities trading software stack, including US market data feeds from Devexperts' own market data provider, dxFeed , as well as integrated execution services. The complete turnkey framework promises a faster time to market, with the ability to embed directly and seamlessly with brokers' existing ecosystems. As a comprehensive technology suite, it also means brokers can rely on one point of contact for the technology's complete delivery and maintenance. The solution provides brokers in South Korea with the opportunity to swiftly position themselves to meet the demands of the country's growing US equities retail trader and investor base. Indeed, estimates suggest retail investors in South Korea are already investing several billions of dollars in US stocks each month. Jon Light, Senior Director of Product Management at Devexperts , says: "The retail investor community in South Korea is taking a very clear interest in the US market. As such, we are pleased to offer brokers in South Korea a complete US equities turnkey solution – including trading platform, market data delivery, and execution services – that enables them to quickly and efficiently deliver the access to US stocks their clients are looking for. Our end-to-end off-the-shelf US equities solution is the only one of its kind and we are excited to be bringing its benefits to the South Korean capital markets." DXtrade is a white-label trading platform solution that allows for full broker branding and customization. It additionally includes industry-standard APIs for seamless integrations with third parties. The platform is available for web and mobile, as well as via a white-label mobile app for iOS and Android. dxFeed is a leading global market data, financial services, and AI- and IaaS-driven solutions provider for the global capital markets, brokerages, prop traders, exchanges, professional traders, and academic institutions worldwide. About Devexperts Devexperts is a software development company that has been serving the needs of capital markets since 2002. To find out more, please visit: https://devexperts.com/ . pr@devexperts.com
2026-09-16 23:00:00

SQC Appoints Semiconductor Veteran John Hollister as Chief Financial Officer
Hollister brings 25+ years of financial leadership across the global semiconductor industry, including previous CFO roles at GlobalFoundries and Silicon Labs SYDNEY , Sept. 16, 2026 /PRNewswire/ -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic-precision manufacturing, today announced the appointment of John Hollister as Chief Financial Officer, effective 17 August 2026. Hollister will lead global financial strategy and operations as SQC advances its roadmap to universal, commercial-scale quantum computers. SQC Chief Financial Officer, John Hollister Based in the U.S., Hollister is a global finance executive with more than two decades of leadership experience within the semiconductor industry. He has led and scaled international teams through periods of accelerated growth, with expertise spanning capital formation, financial planning and analysis, worldwide accounting, financial reporting, M&A, tax and investor relations. Prior to SQC, Hollister served as CFO at GlobalFoundries, one of the world's largest semiconductor foundries. Earlier in his career, he spent two decades at Silicon Labs, including 11 years as the company's CFO, and held previous roles at Cicada Semiconductor and Cirrus Logic. SQC Founder and CEO, Michelle Simmons, said: "Building a globally competitive quantum computing company requires the sharpest minds and deep knowledge. John brings a track record of financial rigor and expertise that is critical to advancing our commercial roadmap and scaling our world-leading manufacturing technology. We are delighted to have him on board." SQC Chief Financial Officer, John Hollister, added : "I look forward to building the financial infrastructure to support SQC's next phase of growth, both in Australia and globally. Bringing quantum computing to the world is a massive opportunity, and SQC's atomic-precision manufacturing capability gives us a distinct commercial and scientific advantage." Hollister's arrival follows the appointment of Karna Nisewaner as Chief Legal Officer in June 2026. Together, these appointments bolster SQC's executive leadership with decades of expertise building and running the operational machine behind chip design and manufacturing. SQC is one of 11 companies selected for Stage B of DARPA's Quantum Benchmarking Initiative, and the company continues to deploy its quantum-enhanced AI and materials simulation chips to customers today. For more information, visit www.sqc.com and follow SQC on LinkedIn . About Silicon Quantum Computing Silicon Quantum Computing (SQC) is at the forefront of global efforts to deliver a commercial-scale quantum system. Backed by 25 years of technological leadership, SQC holds a singular advantage: exclusive capability to manufacture silicon chips with atomic precision, enabling quantum computing systems with world-leading algorithmic fidelity. With in-house QPU manufacturing, SQC iterates new chips weekly while delivering quantum-enhanced AI and materials simulation systems to customers today. The company was founded in 2017 and is headquartered in Sydney, Australia. Media Contact press@sqc.com
2026-09-15 21:00:00

What are you doing?

0.014909029006958


News
News
Tajikistan
Latest News and Headlines
Tajikistan
News